Ann Arbor, MI, United States of America

Yuting Kuang

This inventor holds 1 USPTO granted patent. Top assignees: The University of Texas System, University of Michigan. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuting Kuang: Innovator in Medicinal Chemistry

Introduction

Yuting Kuang is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer treatment. His innovative work has the potential to impact the lives of many individuals affected by cancer.

Latest Patents

Yuting Kuang holds a patent for "Substituted amides for treating and preventing cancer." This invention focuses on small molecule compounds with a quinolin-8-yl-nicotinamide structure. These compounds are designed to treat, ameliorate, or prevent various forms of cancer, including pancreatic cancer. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Yuting Kuang has worked with prestigious institutions such as the University of Texas System and the University of Michigan. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yuting has collaborated with notable colleagues, including Na Ye and Nouri Neamati. These partnerships have enriched his research and expanded the scope of his innovative work.

Conclusion

Yuting Kuang is a dedicated inventor whose work in medicinal chemistry is paving the way for new cancer treatments. His contributions are vital to the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…